News & Events | FDA
FDA news releases, media contacts, speeches, meetings and workshops, and other ways that FDA engages with the public.
FDA Newsroom | FDA
The latest news and events at the U.S. Food and Drug Administration (FDA) and resources for journalists.
U.S. Food and Drug Administration
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this ...
Press Announcements | FDA
Note: Press announcements from 2004-2012, 2013-2016, 2017, 2018-2020, 2021, 2022, and 2023 are available through the FDA.gov Archive. Some links in press announcements may no longer be active.
FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
Feb 6, 2026 · Today, the U.S. Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA …
News & Events for Human Drugs | FDA
FDA Newsroom The latest news and events at the U.S. Food and Drug Administration (FDA)
What's New Related to Drugs | FDA
Jan 27, 2026 · Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.
Drugs | FDA - U.S. Food and Drug Administration
FDA uses science and data to ensure that approved drugs are of a high quality, safe, and effective. Learn more about the FDA’s role in reviewing, approving, and monitoring drugs in the latest ...
FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and ...
Dec 15, 2025 · The U.S. Food and Drug Administration (FDA) today removed a key limitation on the use of real-world evidence (RWE) used in drug and device applications reviews.
Novel Drug Approvals for 2025 | FDA
Feb 4, 2026 · We also made other important approval decisions, such as approving previously approved drugs for new uses and broader patient populations. CDER’s novel drug approvals for 2025 are …